Clal Electronics Industries

Clal Biotechnology Industries (CBI) is a leading Israeli investment company focused on the life sciences sector. Established in 1998 and headquartered in Tel Aviv, CBI identifies, funds, and manages innovative biotechnology companies, particularly those emerging from Israeli research institutions. The company's portfolio includes a diverse range of therapeutic areas such as oncology, hematology, and regenerative medicine, with investments spanning from early-stage startups to mature, publicly traded companies. CBI provides strategic guidance and financial support to its portfolio entities, aiming to bring breakthrough medical treatments to the global market. The company is publicly traded on the Tel Aviv Stock Exchange and is a central figure in the Israeli high-tech and bio-pharma ecosystem.